Completed
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
NCT03078751
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Arizona Oncology Associates PC- HAL Tucson, Arizona, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
- CBCC Global Research Bakersfield, California, United States
- University of California - Los Angeles Los Angeles, California, United States